The Role of Gut Bacteria in the Metabolism of Dietary Xylitol

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Gut Bacteria in the Metabolism of Dietary Xylitol THE ROLE OT' GUT BACTERIA IN THE METASOLISM OF DIETARY XN,ITOL by RAVI KRISHNAI{ BSc. (Hon.) Department of Pathology, Faculty of Medicine, Universi-ty of Adelaide and Metabolic Research Group, DívÍsion of Clinical Ghemistry, Instit.uÈe of Medi-cal and Veterinary Science, Adelaide, South Australia. Beíng a thesis submitted to the Unlversity of Adelalde for the degree of Doctor of Phl-losoPhy. March 1984 "Reading makeEh a ful1 man; conference a ready man; and wrítíng an exact man.tt Francis Bacon, from "Essays-Civil and Moral, sub-heading- 0f StudÍes" In dedícation of: my grandfather who was the motivating influence in all my academic endeavours; my mother and father for their l¡/armth and support; my sister and brothers for raising my morale; my wife for her 1ove. 1 CONTENTS Declaration vr- Acknowledgements vl_1 Abstract vr-r-]- Enzyme Nomenclature l_x CHAPTER ONE DIETARY XYLITOL AND OSMOTIC DIARRTIOEA: MECHANTSMS OF IIOST ADAPTATION I INTRODUCTION I SUCROSE SUBSTITUTES 1 occuRRENCE, MANUFACTUR-E AI{D USE OF XYLTTOL 2 METABOLISM OF XYI,ITOL 3 THE USE OF XYLITOL AS A PARENTERAL NUTRIENT 6 SIDE-EFFECTS AND TOXIC RXACTIONS OF DIETARY XYLITOL IN ANIMAL STUDIES 7 DIETARY XYLITOL IN IIU},IAN CLINICAL TRIALS 9 SUMMARY OF XYLITOI DIETARY STUDIES IN HIN.{ANS AND ANIMALS t0 MECHANISMS OF ADAPTATION TO XYLITOL-INDUCED DIARRHOEA 11 Liver 13 cut ülal-I r3 Gut Lumen L4 MICROBIAL METASOLISM OF XYLITOL L4 AIMS OF THESIS 16 l_ l_ CHAPTER TI,TO STUDIES ON THE ADAPTATION ASSOCIATED I{ITTI )TY.LITOL INGESTION IN RATS: A ROLE FOR GUT MICROT'LORA 18 INTRODUCTION r8 MATERIAIS AND METHODS L9 Laboratory Supplíes 19 Animals and Diet 20 Tissue PreparaËions and Assay Conditions 20 Preparatíon of Caecal Flora Samples 22 Radioisotopie Metabolic AssaY 22 RNSULTS 22 The EffecËs of Dietary Carbohydrates on Liver Function 22 The Effect of Dietary Xylitol on Certain Biochemical Values of Plasma 24 The Effect of Dietary Xylítol on other Biological Parameters ín the Rat 27 The Effect of Xylitol on the Caecal Contents of Rats 30 Dietary Xylitol and Microbial Composition of Caecal tr'lora 30 14CO" Gut Commensal Production of from Labelled Carbo- hydrates 32 Effect of DieËary Xylitol on the Metabolisrn of Xylitol by Caecal Flora 35 Effect of Dietary carbohydrates on carbohydrate Metabolísm by Caecal Flora 38 DISCUSSION 39 CHAPTER TI^IO APPENDIX A IIECHANISM FOR THE THIAMIN-SPARING ACTION OF DIETARY XYI,ITOL IN TI1E RAT 4s INTRODUCTION 45 MATERIAIS AND METHODS 45 Animals 46 DieÈ 46 In vivo experiments 46 l_ tl_ In vitro experiments 46 Measurement of xylitol and glucose metabolisrn by caecal mi-crof lora 4l Measurement of thiamín and thíamin pyrophosphate 47 Protein determination 47 Statist Ícs 48 RESIILTS 4B Reversal of weight loss in vitanin-deficienË rats by xylitol 4B Effect of xylitol on the caecum of vitamin-deficj-ent rats 4B Effect of xylitol on glucose and xylitol metabolísm 50 Thiamín pyrophosphate conËent of caecum and liver 50 In vitro growth of caecal microflora on xylitol 55 DISCUSSION 55 CHAPTER THREE THE ISOLATION AND CHARACTERISATION OF XYLITOL- UTILISING BACTERIA FROM THE RAT CAECIJM 59 INTRODUCTION 59 MATERIA],S AND METHODS 60 Media and Culture Techníques 60 Determination of Viable Numbers of Bactería 6I Identificatíon of Bacteria 6L Radioisotopic Assay of Bacterial Xylitol-metabolising Activity 62 RESULTS 63 Aerobic Isolation of BacËeria from the Rat Caecum 63 Ammonium Sulphate Agar Plates 63 Yeast Extract Agar Plates 65 Glucose- and Xylitol-metabolising Activities of Bacterial Isolates from the Rat Caecum 65 Effect of Díetary Xylitol on the Populations of Caecal Bacteri-a 69 l_v DISCUSSION 73 CHAPTER FOUR THE UTILISATION OF XYLITOL BY KLEBSIELI,A PNEIMONIAE AND SERRATIA LIQUEFACIENS 18 INTRODUCTION 78 MATERIA],S AND METIIODS 81 Media and Growth Conditions 81 Preparatíon of Bacterial Cell-Free Extracts 82 Polyol Dehydrogenase Assay 82 Pentulokínase Assay 83 Transport Assay 83 Radioísotopic Metabolic Assay 84 RESULTS 84 Effect of CarbohydraÈe Growth Substrates on the Xylitol- metabolising activity of K.pneunoniae and S.liquefaciens 84 Effect of Carbohydrate Growth Substrates on the Uptake of Xylitol and Sorbitol 86 Cornpetition of Xylitol and Sorbítol Uptake by other Sugar Polyols B9 Effect of Carbohydrate Growth Substrates on the Pqlyol Dehydrogenase Activities found in Cel1-free Extracts of K. pneumoniae and S.1íquefaciens 89 Pentulokinase Activíties in K.pneumoniae and s.1i uefaciens 93 DISCUSSION 95 CHAPTER FIVE AN EXAMINATION OF THE INSOLUBLE MUCUS-LIKE MATERIAL THAT ACCI]MULATES IN THE CAECI]M OF XY-I,ITOL-FED RATS 100 INTRODUCTION 100 MATERIALS AND METHODS 103 Preparation of Fluffy Layer 103 (i) From Caecal Contents of Rats 103 ( ii) From Cultures of K.pneumoniae LO4 v Comparative Carbohydrate Study 104 1L -'C-labellíng of the Fluffy Layer Produced by K.pneumoníae in Culture 104 Alkaline Extraction of the Fluffy Layers 104 Isolation of the Polysaccharide Component of the Cornbined Fluffy Layer and Bacterial Pellet 105 Chemical Analysis ro7 Identifícation of Sugars 107 RESULTS 108 Characterisation of the Fluffy Layer r08 The effect of Carbohydrate Substrates on the Production of the Fluffy Layer 110 Alkaline Extract of the Fluffy Layer 110 Purífícation of the Polysaccharide Component of the Fluffy Layer 115 Identification of NeuÈral Sugars in Acid Hydrolysates of Polysaccharides 115 DISCUSSION L22 CHAPTER SIX L24 CONCLUDING REMARKS L24 FUTURE EXPERIMM{TS l-28 Long-term Dietary Studies 128 Anaerobic Bacterial Metabolísrn of Xylitol I29 Contínuous Culture Experlments with Caecal ConÈents L29 Effect of Antibiotics on Fluffy Layer Production 130 CONCLUSION 130 BIBLIOGRAPHY r33 PUBLICATIONS L47 vl- DECLARATION Ïhis thesis contains no materíal which has been accepted for the award of any other degree or diploma ín any other uníversity. In addÍ.tÍon, to the best of my knowledge and belief, this thesis contains no material previously published or r¿ritten by another person, except when due reference is made in the text of this thesis. Ravi Krfshnan v1a ACKNOI^ILEDGEMENTS The completion of this thesis owes much to many people and, in ¡rarLicular, Lhanks are clue Lt¡ LLe fullr.rwiug ¡reu¡rle: ury supervlsor, Dr. E.G. Cleary, especially for his help in the preparation of this thesis, and Dr. R.A.J. Conyers and Dr. J.B. Edwards for theír overall guidance and advice throughout the work and in the preparation of this thesís " I am particularly indebted to Bob Conyers for his patíence, persistent ericouragement and generosíty with his time. Special thanks are also due to Dr. A.M. Rofe for hís valued criticísm and his work done in conjunction with me in the study of the vj-tamin-sparing action of xylitol in rats. Dr. R. Baisrs constructive reviehr and criticísms of my Ëhesis are grate- ful1y acknowledged. I have also benefited iuunensely from the technical expertise of Mr. N. Potezny and Mr. P. Coyle who were always ready to help. I thank my co-\^/orkers in the MetabolÍc Research Group and Ëhe staff of the Divisions of Clinical Chemistry, Clinical Microbíology and Tissue Pathology. Of particular note, \^¡ere the gas chronatographic/mass spectroscopic analyses performed by Mr. C. Hann; assístance in Ëhe identification of bacterial isolates by Ms. L. Joyce and Mrs. I. I^Iilkinson and the electronmicrr..rscopy performed by Mr. B. Dixon. Thanks are also due to Mrs. M. Edwards for the excellent typing of this thesis. I gratefully acknowledge the encouragement and support of Dr. B.J. Kearney, Dr. R.G. Edwards and Dr. D.I^I . Thomas who allowed me to undertake this work in the Division of Clinical Chemistry at the Institute of Medical and Veterinary Science. The provision of an I.M.V.S. postgraduate studentship is also gratefully acknowledged. Finally, thís work was also made possible through the financial support of the Metabolic Research Group by the National Health and Medícal Research Council, Australia; The Anti- Cancer Foundation of the Universitíes of South Australia; Roche Products Pty. Ltd., Australia and Esso (Australia) Ltd. vala ABSTRACT THE ROLE OF GUT BACTERIA IN THE METASOLISM OF DIETARY XYLITOT. Ravi KRISHNAN, University of Adelaide. Ph.D. Thesis; March L984. xylitol' a sugar polyor, will be increasingly used as a nutritÍve, anti-cariogenic, sugar substitute. rn both man and animals, however, the Íngestion of relatively large amounts of xylitol is often accompanied by an osmotic diarrhoea. Persistence with xylitol díets results in an adaptation (i.e. cessatíon of diarrhoea) and the ability to tolerate much greater amounts of dietary xylitol. rt is argued ín chapter one that the mechanism of adaptation oceurs either by increasing Èhe xyliÈo1- metabolising abilíty of the microflora in the gut lumen; the gut wall mucosa or the 1iver. rn chapter Tr¿o it is shovm that the plasma meÈabolite and electrol yte concen trations hepatic enzyme activíties and líver homo genate metabolism of 114 C -labelled carbohydrates are similar in both xylitol-adapted and non-adapted rats. 0n the other hand, xylitol-adapt ed rats have enlarged caeca with increased amounts of gas, acidity and thaam].n. lüith use of the a sensÍtive radio isotopic assay, the caecal microflora revealed a xyl i t ol -rnetab o1 is Ín g abi-1ity and, in the presence of x1,li¡el díets thís could , increase 40-fol d. In further studies reported in Ch apter Three, s .1i uefaciens and r¿ere identified as caecal bacteria capable of growth on xylitol. The in vitro studies reported in Chapter Four indicated that the induction of a xylitol transport protein, a xylitol dehydroeenase and axv lulokinase l4cõz are essential for the increased production of- fro* lu_t4c"l xylitol. Bacterial growth on arabitol, ribitol or sorbitol demonstrated neither inductj-on of all these enzyme activities nor enhancement of xylitol met abolism.
Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • Proteome Analysis of Xylose Metabolism in Rhodotorula Toruloides During Lipid Production Ievgeniia A
    Tiukova et al. Biotechnol Biofuels (2019) 12:137 https://doi.org/10.1186/s13068-019-1478-8 Biotechnology for Biofuels RESEARCH Open Access Proteome analysis of xylose metabolism in Rhodotorula toruloides during lipid production Ievgeniia A. Tiukova1,2* , Jule Brandenburg2, Johanna Blomqvist2,3, Sabine Sampels2, Nils Mikkelsen2, Morten Skaugen4, Magnus Ø. Arntzen4, Jens Nielsen1, Mats Sandgren2 and Eduard J. Kerkhoven1 Abstract Background: Rhodotorula toruloides is a promising platform organism for production of lipids from lignocellulosic substrates. Little is known about the metabolic aspects of lipid production from the lignocellolosic sugar xylose by oleaginous yeasts in general and R. toruloides in particular. This study presents the frst proteome analysis of the metabolism of R. toruloides during conversion of xylose to lipids. Results: Rhodotorula toruloides cultivated on either glucose or xylose was subjected to comparative analysis of its growth dynamics, lipid composition, fatty acid profles and proteome. The maximum growth and sugar uptake rate of glucose-grown R. toruloides cells were almost twice that of xylose-grown cells. Cultivation on xylose medium resulted in a lower fnal biomass yield although fnal cellular lipid content was similar between glucose- and xylose-grown cells. Analysis of lipid classes revealed the presence of monoacylglycerol in the early exponential growth phase as well as a high proportion of free fatty acids. Carbon source-specifc changes in lipid profles were only observed at early exponential growth phase, where C18 fatty acids were more saturated in xylose-grown cells. Proteins involved in sugar transport, initial steps of xylose assimilation and NADPH regeneration were among the proteins whose levels increased the most in xylose-grown cells across all time points.
    [Show full text]
  • Xylose Fermentation to Ethanol by Schizosaccharomyces Pombe Clones with Xylose Isomerase Gene." Biotechnology Letters (8:4); Pp
    NREL!TP-421-4944 • UC Category: 246 • DE93000067 l I Xylose Fermenta to Ethanol: A R ew '.) i I, -- , ) )I' J. D. McMillan I ' J.( .!i �/ .6' ....� .T u�.•ls:l ., �-- • National Renewable Energy Laboratory II 'J 1617 Cole Boulevard Golden, Colorado 80401-3393 A Division of Midwest Research Institute Operated for the U.S. Department of Energy under Contract No. DE-AC02-83CH10093 Prepared under task no. BF223732 January 1993 NOTICE This report was prepared as an account of work sponsored by an agency of the United States government. Neither the United States government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, com­ pleteness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily con­ stitute or imply its endorsement, recommendation, or favoring by the United States government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States government or any agency thereof. Printed in the United States of America Available from: National Technical Information Service U.S. Department of Commerce 5285 Port Royal Road Springfield, VA22161 Price: Microfiche A01 Printed Copy A03 Codes are used for pricing all publications. The code is determined by the number of pages in the publication. Information pertaining to the pricing codes can be found in the current issue of the following publications which are generally available in most libraries: Energy Research Abstracts (ERA); Govern­ ment Reports Announcements and Index ( GRA and I); Scientific and Technical Abstract Reports(STAR); and publication NTIS-PR-360 available from NTIS at the above address.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0155567 A1 Burk Et Al
    US 2014O155567A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0155567 A1 Burk et al. (43) Pub. Date: Jun. 5, 2014 (54) MICROORGANISMS AND METHODS FOR (60) Provisional application No. 61/331,812, filed on May THE BIOSYNTHESIS OF BUTADENE 5, 2010. (71) Applicant: Genomatica, Inc., San Diego, CA (US) Publication Classification (72) Inventors: Mark J. Burk, San Diego, CA (US); (51) Int. Cl. Anthony P. Burgard, Bellefonte, PA CI2P 5/02 (2006.01) (US); Jun Sun, San Diego, CA (US); CSF 36/06 (2006.01) Robin E. Osterhout, San Diego, CA CD7C II/6 (2006.01) (US); Priti Pharkya, San Diego, CA (52) U.S. Cl. (US) CPC ................. CI2P5/026 (2013.01); C07C II/I6 (2013.01); C08F 136/06 (2013.01) (73) Assignee: Genomatica, Inc., San Diego, CA (US) USPC ... 526/335; 435/252.3:435/167; 435/254.2: (21) Appl. No.: 14/059,131 435/254.11: 435/252.33: 435/254.21:585/16 (22) Filed: Oct. 21, 2013 (57) ABSTRACT O O The invention provides non-naturally occurring microbial Related U.S. Application Data organisms having a butadiene pathway. The invention addi (63) Continuation of application No. 13/101,046, filed on tionally provides methods of using Such organisms to produce May 4, 2011, now Pat. No. 8,580,543. butadiene. Patent Application Publication Jun. 5, 2014 Sheet 1 of 4 US 2014/O155567 A1 ?ueudos!SMS |?un61– Patent Application Publication Jun. 5, 2014 Sheet 2 of 4 US 2014/O155567 A1 VOJ OO O Z?un61– Patent Application Publication US 2014/O155567 A1 {}}} Hººso Patent Application Publication Jun.
    [Show full text]
  • Pyruvate-Phosphate Dikinase of Oxymonads and Parabasalia and the Evolution of Pyrophosphate-Dependent Glycolysis in Anaerobic Eukaryotes† Claudio H
    EUKARYOTIC CELL, Jan. 2006, p. 148–154 Vol. 5, No. 1 1535-9778/06/$08.00ϩ0 doi:10.1128/EC.5.1.148–154.2006 Copyright © 2006, American Society for Microbiology. All Rights Reserved. Pyruvate-Phosphate Dikinase of Oxymonads and Parabasalia and the Evolution of Pyrophosphate-Dependent Glycolysis in Anaerobic Eukaryotes† Claudio H. Slamovits and Patrick J. Keeling* Canadian Institute for Advanced Research, Botany Department, University of British Columbia, 3529-6270 University Boulevard, Vancouver, British Columbia V6T 1Z4, Canada Received 29 September 2005/Accepted 8 November 2005 In pyrophosphate-dependent glycolysis, the ATP/ADP-dependent enzymes phosphofructokinase (PFK) and pyruvate kinase are replaced by the pyrophosphate-dependent PFK and pyruvate phosphate dikinase (PPDK), respectively. This variant of glycolysis is widespread among bacteria, but it also occurs in a few parasitic anaerobic eukaryotes such as Giardia and Entamoeba spp. We sequenced two genes for PPDK from the amitochondriate oxymonad Streblomastix strix and found evidence for PPDK in Trichomonas vaginalis and other parabasalia, where this enzyme was thought to be absent. The Streblomastix and Giardia genes may be related to one another, but those of Entamoeba and perhaps Trichomonas are distinct and more closely related to bacterial homologues. These findings suggest that pyrophosphate-dependent glycolysis is more widespread in eukaryotes than previously thought, enzymes from the pathway coexists with ATP-dependent more often than previously thought and may be spread by lateral transfer of genes for pyrophosphate-dependent enzymes from bacteria. Adaptation to anaerobic metabolism is a complex process (PPDK), respectively (for a comparison of these reactions, see involving changes to many proteins and pathways of critical reference 21).
    [Show full text]
  • Characterization of a Eukaryotic Type Serine/Threonine Protein Kinase And
    Characterization of a eukaryotic type serine/threonine protein kinase and protein phosphatase of Streptococcus pneumoniae and identification of kinase substrates Linda Nova´ kova´ 1, Lenka Saskova´ 1, Petra Pallova´ 1, Jirˇı´ Janecˇek1, Jana Novotna´ 1, Alesˇ Ulrych1, Jose Echenique2, Marie-Claude Trombe3 and Pavel Branny1 1 Cell and Molecular Microbiology Division, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic 2 Departamento de Bioquı´mica Clı´nica, Facultad de Ciencias Quı´micas, Universidad Nacional de Co´ rdoba, Medina Allende esq Haya de la Torre, Ciudad Universitaria, Co´ rdoba, Argentina 3 Centre Hospitalo-Universitaire de Rangueil, Universite´ Paul Sabatier, Toulouse, France Keywords Searching the genome sequence of Streptococcus pneumoniae revealed the phosphoglucosamine mutase; presence of a single Ser ⁄ Thr protein kinase gene stkP linked to protein phosphoproteome; protein phosphatase; phosphatase phpP. Biochemical studies performed with recombinant StkP serine ⁄ threonine protein kinase; suggest that this protein is a functional eukaryotic-type Ser ⁄ Thr protein Streptococcus pneumoniae kinase. In vitro kinase assays and Western blots of S. pneumoniae subcellu- Correspondence lar fractions revealed that StkP is a membrane protein. PhpP is a soluble P. Branny, Cell and Molecular Microbiology protein with manganese-dependent phosphatase activity in vitro against a Division, Institute of Microbiology, Czech synthetic substrate RRA(pT)VA. Mutations in the invariant aspartate resi- Academy of Sciences, Vı´denˇ ska´ 1083, dues implicated in the metal binding completely abolished PhpP activity. 142 20 Prague 4, Czech Republic Autophosphorylated form of StkP was shown to be a substrate for PhpP. Fax: +420 2 41722257 These results suggest that StkP and PhpP could operate as a functional Tel: +420 2 41062658 E-mail: [email protected] pair in vivo.
    [Show full text]
  • Table 6. Putative Genes Involved in the Utilization of Carbohydrates in G
    Table 6. Putative genes involved in the utilization of carbohydrates in G. thermodenitrificans NG80-2 genome Carbohydrates* Enzymes Gene ID Glycerol Glycerol Kinase GT1216 Glycerol-3-phosphate dehydrogenase, aerobic GT2089 NAD(P)H-dependent glycerol-3-phosphate dehydrogenase GT2153 Enolase GT3003 2,3-bisphosphoglycerate-independentphosphoglycerate mutase GT3004 Triosephosphate isomerase GT3005 3-phosphoglycerate kinase GT3006 Glyceraldehyde-3-phosphate dehydrogenase GT3007 Phosphoglycerate mutase GT1326 Pyruvate kinase GT2663 L-Arabinose L-arabinose isomerase GT1795 L-ribulokinase GT1796 L-ribulose 5-phosphate 4-epimerase GT1797 D-Ribose Ribokinase GT3174 Transketolase GT1187 Ribose 5-phosphate epimerase GT3316 D-Xylose Xylose kinase GT1756 Xylose isomerase GT1757 D-Galactose Galactokinase GT2086 Galactose-1-phosphate uridyltransferase GT2084 UDP-glucose 4-epimerase GT2085 Carbohydrates* Enzymes Gene ID D-Fructose 1-phosphofructokinase GT1727 Fructose-1,6-bisphosphate aldolase GT1805 Fructose-1,6-bisphosphate aldolase type II GT3331 Triosephosphate isomerase GT3005 D-Mannose Mannnose-6 phospate isomelase GT3398 6-phospho-1-fructokinase GT2664 D-Mannitol Mannitol-1-phosphate dehydrogenase GT1844 N-Acetylglucosamine N-acetylglucosamine-6-phosphate deacetylase GT2205 N-acetylglucosamine-6-phosphate isomerase GT2204 D-Maltose Alpha-1,4-glucosidase GT0528, GT1643 Sucrose Sucrose phosphorylase GT3215 D-Trehalose Alpha-glucosidase GT1643 Glucose kinase GT2381 Inositol Myo-inositol catabolism protein iolC;5-dehydro-2- GT1807 deoxygluconokinase
    [Show full text]
  • Evolving a New Efficient Mode of Fructose Utilization For
    fbioe-09-669093 May 22, 2021 Time: 22:55 # 1 ORIGINAL RESEARCH published: 28 May 2021 doi: 10.3389/fbioe.2021.669093 Evolving a New Efficient Mode of Fructose Utilization for Improved Bioproduction in Corynebacterium glutamicum Irene Krahn1, Daniel Bonder2, Lucía Torregrosa-Barragán2, Dominik Stoppel1, 1 3 1 3,4 Edited by: Jens P. Krause , Natalie Rosenfeldt , Tobias M. Meiswinkel , Gerd M. Seibold , Pablo Ivan Nikel, Volker F. Wendisch1 and Steffen N. Lindner1,2* Novo Nordisk Foundation Center 1 2 for Biosustainability (DTU Biosustain), Chair of Genetics of Prokaryotes, Faculty of Biology and CeBiTec, Bielefeld University, Bielefeld, Germany, Systems 3 Denmark and Synthetic Metabolism, Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany, Institute of Biochemistry, University of Cologne, Cologne, Germany, 4 Department of Biotechnology and Biomedicine, Technical Reviewed by: University of Denmark, Lyngby, Denmark Stephan Noack, Julich-Forschungszentrum, Helmholtz-Verband Deutscher Fructose utilization in Corynebacterium glutamicum starts with its uptake and Forschungszentren (HZ), Germany concomitant phosphorylation via the phosphotransferase system (PTS) to yield Fabien Létisse, UMR 5504 Laboratoire d’Ingénierie intracellular fructose 1-phosphate, which enters glycolysis upon ATP-dependent des Systèmes Biologiques et des phosphorylation to fructose 1,6-bisphosphate by 1-phosphofructokinase. This is known Procédés (LISBP), France to result in a significantly reduced oxidative pentose phosphate pathway (oxPPP) flux *Correspondence: ∼ ∼ Steffen N. Lindner on fructose ( 10%) compared to glucose ( 60%). Consequently, the biosynthesis of [email protected] NADPH demanding products, e.g., L-lysine, by C. glutamicum is largely decreased when fructose is the only carbon source. Previous works reported that fructose Specialty section: This article was submitted to is partially utilized via the glucose-specific PTS presumably generating fructose 6- Synthetic Biology, phosphate.
    [Show full text]
  • Engineering Zymomonas Mobilis for the Production of Biofuels and Other Value-Added Products
    © 2015 Kori Lynn Dunn ENGINEERING ZYMOMONAS MOBILIS FOR THE PRODUCTION OF BIOFUELS AND OTHER VALUE-ADDED PRODUCTS BY KORI LYNN DUNN DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemical Engineering in the Graduate College of the University of Illinois at Urbana-Champaign, 2015 Urbana, Illinois Doctoral Committee: Associate Professor Christopher V. Rao, Chair Associate Professor Yong-Su Jin Associate Professor Hyunjoon Kong Associate Professor Mary Kraft Abstract Zymomonas mobilis is a promising organism for lignocellulosic biofuel production as it can efficiently produce ethanol from simple sugars using unique metabolic pathways. Z. mobilis displays what is known as the “uncoupled growth” phenomenon, meaning cells will rapidly convert sugars to ethanol regardless of their energy requirements for growth. This makes Z. mobilis attractive not only for ethanol production, but for alternative product synthesis as well. One limitation of Z. mobilis for cellulosic ethanol production is that this organism cannot natively ferment the pentose sugars, like xylose and arabinose, which are present in lignocellulosic hydrolysates. While it has been engineered to do so, the fermentation rates of these sugars are still extremely low. In this work, we have investigated sugar transport as a possible bottleneck in the fermentation of xylose by Z. mobilis. We showed that transport limits xylose fermentations in this organism, but only when the starting sugar concentration is high. To discern additional bottlenecks in pentose fermentations by Z. mobilis, we then used adaptation and high-throughput sequencing to pinpoint genetic mutations responsible for improved growth phenotypes on these sugars. We found that the transport of both xylose and arabinose through the native sugar transporter, Glf, limits pentose fermentations in Z.
    [Show full text]
  • Development and Control of Intestinal and Hepatic Fructokinase
    INTESTINAL AND HEPATIC FRUCTOKINASE 765 expansion on intrarenal distribution of plasma flow in the dog. 42. The authors acknowledge the expert assistance of Mrs. Ann- Amer. J. Physiol., 223: 125 (1972). Christine Eklof and Mr. Gothe Carlebjork. 37. West, G. R., Smith, H. W., and Chasis, H.: Glomerular filtration 43. This research was supported by Grant no. B74-19X-3644-03Bfrom rate, effective renal blood flow and maximal tubular excretory the Swedish Medical Research Council and by a grant from the capacity in infancy. J. Pediat., 32: 10 (1948). Prenatal Research Funds of Expressen. 38. Laevosan Gesellschaft, Linz, Austria. 44. Requests for reprints should be addressed to: P. Herin, M.D., 39. 3M Company, St. Paul, Minn. Karolinski Institutet, Pediatriska Kliniken, St: Goran's Barn- 40. Sage Instruments, Inc., White Plains, N. Y. liniker, Box 12500, 112 81 Stockholm, Sweden. 41. Gilford Instrument Labs., Inc., Oberlin, Ohio. 45. Accepted for publication April 4, 1974. Copyright O 1974 International Pediatric Research Foundation, Inc. Printed in U.S.A. Pediat. Res. 8: 765-770 (1974) Developmental biochemistry intestine fetus liver fruct okinase Development and Control of Intestinal and Hepatic Fructokinase RICHARD J. GRAND,(^') MARIA I. SCHAY, AND STEPHANIE JAKSINA Department of Pediatrics, Harvard Medical School, and the Department of Medicine (Division of Clinical Nutrition), the Children's Hospital Medical Center, Boston, Massachusetts, USA Extract experimental animals (1, 2, 20, 26) and in man (I 5), although the mechanism of this regulation has not yet been elucidated. The patterns of development of intestinal and hepatic In the rat, adrenalectomy prevents the rise in the activity of fructokinase have been studied in the rat, in the rabbit, and in the hepatic enzyme expected after fructose feeding; hydro- man, and information regarding the mechanism of control of cortisone administered to the intact animal greatly enhances this enzyme in mature organs has been obtained.
    [Show full text]
  • Production of Fuels and Chemicals from Xylose by Engineered Saccharomyces Cerevisiae: a Review and Perspective Suryang Kwak and Yong‑Su Jin*
    Kwak and Jin Microb Cell Fact (2017) 16:82 DOI 10.1186/s12934-017-0694-9 Microbial Cell Factories REVIEW Open Access Production of fuels and chemicals from xylose by engineered Saccharomyces cerevisiae: a review and perspective Suryang Kwak and Yong‑Su Jin* Abstract Efcient xylose utilization is one of the most important pre-requisites for developing an economic microbial conver‑ sion process of terrestrial lignocellulosic biomass into biofuels and biochemicals. A robust ethanol producing yeast Saccharomyces cerevisiae has been engineered with heterologous xylose assimilation pathways. A two-step oxi‑ doreductase pathway consisting of NAD(P)H-linked xylose reductase and NAD­ +-linked xylitol dehydrogenase, and one-step isomerase pathway using xylose isomerase have been employed to enable xylose assimilation in engi‑ neered S. cerevisiae. However, the resulting engineered yeast exhibited inefcient and slow xylose fermentation. In order to improve the yield and productivity of xylose fermentation, expression levels of xylose assimilation pathway enzymes and their kinetic properties have been optimized, and additional optimizations of endogenous or heter‑ ologous metabolisms have been achieved. These eforts have led to the development of engineered yeast strains ready for the commercialization of cellulosic bioethanol. Interestingly, xylose metabolism by engineered yeast was preferably respiratory rather than fermentative as in glucose metabolism, suggesting that xylose can serve as a desir‑ able carbon source capable of bypassing metabolic barriers exerted by glucose repression. Accordingly, engineered yeasts showed superior production of valuable metabolites derived from cytosolic acetyl-CoA and pyruvate, such as 1-hexadecanol and lactic acid, when the xylose assimilation pathway and target synthetic pathways were optimized in an adequate manner.
    [Show full text]
  • Regulation of Fructose-6-Phosphate 2-Kinase By
    Proc. Natt Acad. Sci. USA Vol. 79, pp. 325-329, January 1982 Biochemistry Regulation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation: Possible mechanism for coordinated control of glycolysis and glycogenolysis (phosphofructokinase) EISUKE FURUYA*, MOTOKO YOKOYAMA, AND KOSAKU UYEDAt Pre-Clinical Science Unit of the Veterans Administration Medical Center, 4500 South Lancaster Road, Dallas, Texas 75216; and Biochemistry Department of the University ofTexas Health Science Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235 Communicated by Jesse C. Rabinowitz, September 28, 1981 ABSTRACT The kinetic properties and the control mecha- Fructose 6-phosphate + ATP nism of fructose-6-phosphate 2-kinase (ATP: D-fructose-6-phos- -3 Fructose + ADP. [1] phate 2-phosphotransferase) were investigated. The molecular 2,6-bisphosphate weight of the enzyme is -100,000 as determined by gel filtration. The plot of initial velocity versus ATP concentration is hyperbolic We have shown that the administration of extremely low con- with a K. of 1.2 mM. However, the plot of enzyme activity as a centrations of glucagon (0.1 fM) or high concentrations of epi- function of fructose 6-phosphate is sigmoidal. The apparent K0.5 nephrine (10 ,uM) to hepatocytes results in inactivation offruc- for fructose 6-phosphate is 20 ,IM. Fructose-6-phosphate 2-kinase tose-6-phosphate 2-kinase and concomitant decrease in the is inactivated by -the catalytic subunit of cyclic AMP-dependent fructose 2,6-bisphosphate level (12). These results, as well as protein kinase, and the inactivation is closely correlated with phos- more recent data using Ca2+ and the Ca2+ ionophore A23187 phorylation.
    [Show full text]